ORUKA THERAPEUTICS, INC.Ceo Offer Letter Agreement • May 14th, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 14th, 2024 Company IndustryOn behalf of the Board of Directors of Oruka Therapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Executive Officer of the Company (“CEO”) and a member of the Company’s Board of Directors (the “Board”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below. This Agreement amends and restates that certain letter agreement dated February 6, 2024.